Literature DB >> 8637883

p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues.

R Dikstein1, R Agami, D Heffetz, Y Shaul.   

Abstract

EP is a DNA element found in the enhancer and promoter regions of several cellular and viral genes. Previously, we have identified the DNA binding p140/c-Abl protein that specifically recognizes this element. Here we show that phosphorylation is essential for the p140/c-Abl DNA binding activity and for the formation of DNA-protein complexes. Furthermore, by 32P labeling of cells and protein purification, we demonstrate that in vivo the EP-DNA-associated p140/c-Abl is a tyrosine phosphoprotein. By employing two different c-Abl antibodies, we demonstrate the existence of two distinct c-Abl populations in cellular extracts. p140/c-Abl is quantitatively the minor population, is heavily phosphorylated at both serine and tyrosine residues, and is active in autophosphorylation reactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8637883      PMCID: PMC39806          DOI: 10.1073/pnas.93.6.2387

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.

Authors:  B J Mayer; P K Jackson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 2.  Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia.

Authors:  G Q Daley; Y Ben-Neriah
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

3.  Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region.

Authors:  P Ostapchuk; G Scheirle; P Hearing
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

Review 4.  abl genes.

Authors:  L Ramakrishnan; N Rosenberg
Journal:  Biochim Biophys Acta       Date:  1989-12-17

5.  Functional organization of the hepatitis B virus enhancer.

Authors:  R Dikstein; O Faktor; R Ben-Levy; Y Shaul
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

6.  A single polypeptide possesses the binding and transcription activities of the adenovirus major late transcription factor.

Authors:  L A Chodosh; R W Carthew; P A Sharp
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations.

Authors:  P L Schwartzberg; A M Stall; J D Hardin; K S Bowdish; T Humaran; S Boast; M L Harbison; E J Robertson; S P Goff
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents.

Authors:  S Kharbanda; R Ren; P Pandey; T D Shafman; S M Feller; R R Weichselbaum; D W Kufe
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

10.  N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.

Authors:  P Jackson; D Baltimore
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  4 in total

1.  The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.

Authors:  Y Katan; R Agami; Y Shaul
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

2.  p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53.

Authors:  A Ori; A Zauberman; G Doitsh; N Paran; M Oren; Y Shaul
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

3.  A novel transcriptional factor with Ser/Thr kinase activity involved in the transforming growth factor (TGF)-beta signalling pathway.

Authors:  S Ohta; M Takeuchi; M Deguchi; T Tsuji; Y Gahara; K Nagata
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

4.  Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase.

Authors:  S Taagepera; D McDonald; J E Loeb; L L Whitaker; A K McElroy; J Y Wang; T J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.